The term sciatica is limited to the pain and irritation in nerve roots from L1 to L4 and may also involve related areas. Many times patients and clinicians use sciatica to describe any pain arising from the lower back and radiating down to the leg. Synonyms for sciatica pain are lumbosacral radicular syndrome, ischias, nerve root pain, and nerve root entrapment.

DelveInsight’s “Sciatica Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Sciatica, historical and forecasted epidemiology as well as the Sciatica market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The key facts of the report:
1. Japan accounted for 4,265,022 diagnosed prevalent cases of Sciatica in 2017, which is expected to increase in the forecast period 2020–2030.
2. The total diagnosed population of Sciatica in the seven major markets was found to be 26,761,073 cases in 2017.

Key benefits of the report:
1. The report covers the descriptive overview of Sciatica, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
2. Comprehensive insight has been provided into the Sciatica epidemiology and treatment in the 7MM
3. Additionally, an all-inclusive account of both the Sciatica current and emerging therapies are provided, along with the assessment of new therapies, which will have an impact on the current Sciatica treatment landscape
4. A detailed review of Sciatica market; historical and forecasted is included in the report, covering drug outreach in the 7MM

“The most prevalent cases of Sciatica were recorded in the United States.”

Download free sample pages: https://www.delveinsight.com/sample-request/sciatica-market

Key pharma players involved:
1. Scilex Holding 
2. Seikagaku Corporation 

Drugs involved in Sciatica market are:
1. SP-102  
2. Condoliase

Click here to download a free sample report.

Table of Contents:
1. Key Insights
2. Executive Summary of Sciatica
3. Competitive Intelligence Analysis for Sciatica
4. Sciatica Market Overview at a Glance
4.1. Sciatica Total Market Share (%) Distribution in 2017
4.2. Sciatica Total Market Share (%) Distribution in 2030
5. Sciatica Disease Background and Overview
6. Patient Journey
7. Sciatica Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Sciatica Treatment
11. Marketed Products
12. Emerging Therapies
13. Access and Reimbursement Overview of Sciatica
14. KOL Views
15. Market Drivers
16. Market Barriers
17. Appendix
18. Bibliography
19. Report Methodology
20. DelveInsight Capabilities
21. Disclaimer
22. About DelveInsight

Related reports:

Sciatica – Epidemiology Forecast to 2030

Sciatica Pipeline Insight, 2020